BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX) Research
The fund primarily aims to generate significant capital appreciation for investors over an extended timeframe. To achieve this, it commits at least 80% of its overall assets to equity instruments, predominantly common stocks, of companies engaged in the health sciences and related fields. This specialized sector encompasses a broad spectrum of businesses, such as those involved in medical equipment and supplies, healthcare service delivery, advanced biotechnology, and pharmaceutical manufacturing. The portfolio maintains a concentrated investment approach, allocating more than 25% of its holdings to these health sciences and associated industries, and it also retains the flexibility to invest in companies based outside the United States.
Market snapshot
- Symbol
- SHSAX
- Price
- $62.83
- Day change
- -0.65%
- Market cap
- $5.8B
- 52-week range
- 56.37-69.46
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Fidelity Select Health Care Portfolio (FSPHX)
- ClearBridge International Growth I (LMGNX)
- Permanent Portfolio Class I (PRPFX)
- T. Rowe Price Balanced I Class (RBAIX)
- BlackRock Health Sciences Opportunities Portfolio Service Shares (SHISX)
- BlackRock Health Sciences Opportunities Portfolio (SHSCX)
- BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX)
- BlackRock Health Sciences Opportunities Portfolio Institutional Shares (SHSSX)
Open BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.